How to Fix FDA
This article was originally published in RPM Report
Executive Summary
FDA's problems are too many to count. Drug safety expert and prominent cardiologist Steve Nissen, MD, says sweeping reforms are the only answer.
You may also be interested in...
Improvements in Preventive Care Lacking
The push to improve healthcare quality in the U.S. has been a consistent goal, imbedded in the industry for years. However, over the last decade this movement rose to a higher level of necessity, and a number of programs have been generated from within the industry as well as government agencies -- but, has significant progress been made?
McClellan's FDA Team
When Mark McClellan became FDA commissioner in late 2002, he brought with him a cadre of like-minded managers and policy advisors. Many were economists; all were advocates for private-sector innovation. Most have departed from FDA. Their departures may have some short-term political benefits for the agency; but they leave a legacy of economic interest in the way FDA works and affects society.
McClellan's FDA Team
When Mark McClellan became FDA commissioner in late 2002, he brought with him a cadre of like-minded managers and policy advisors. Many were economists; all were advocates for private-sector innovation. Most have departed from FDA. Their departures may have some short-term political benefits for the agency; but they leave a legacy of economic interest in the way FDA works and affects society.